|
WO2006071940A2
(en)
|
2004-12-23 |
2006-07-06 |
Deciphera Pharmaceuticals, Llc |
Enzyme modulators and treatments
|
|
DE102006029795A1
(de)
*
|
2006-06-27 |
2008-01-03 |
Schebo Biotech Ag |
Neue Harnstoff-Derivate und deren Verwendungen
|
|
WO2008026704A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Kyowa Hakko Kogyo Co., Ltd. |
Isoquinoline derivative
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
EA200900573A1
(ru)
*
|
2006-10-20 |
2009-10-30 |
АйАрЭм ЭлЭлСи |
Композиции и способы для модуляции рецепторов c-kit и pdgfr
|
|
WO2008058037A1
(en)
*
|
2006-11-03 |
2008-05-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
KR20100014811A
(ko)
*
|
2007-04-20 |
2010-02-11 |
데시페라 파마슈티칼스, 엘엘씨. |
골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제
|
|
US20110189167A1
(en)
*
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
EP2152688A1
(en)
|
2007-05-04 |
2010-02-17 |
Irm Llc |
Compounds and compositions as c-kit and pdgfr kinase inhibitors
|
|
CA2697077C
(en)
|
2007-08-22 |
2012-10-16 |
Irm Llc |
2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
|
|
CA2697081C
(en)
|
2007-08-22 |
2013-04-23 |
Irm Llc |
5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors
|
|
CA2714700C
(en)
*
|
2008-02-22 |
2013-07-30 |
Irm Llc |
Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
|
|
CN102186809A
(zh)
|
2008-08-14 |
2011-09-14 |
拜尔农作物科学股份公司 |
杀虫性的4-苯基-1h-吡唑
|
|
MY159230A
(en)
|
2008-10-02 |
2016-12-30 |
Respivert Ltd |
P38 map kinase inhibitors
|
|
GB0818033D0
(en)
|
2008-10-02 |
2008-11-05 |
Respivert Ltd |
Novel compound
|
|
CN102256493A
(zh)
*
|
2008-10-29 |
2011-11-23 |
迪赛孚尔制药有限公司 |
表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
|
|
JP5670912B2
(ja)
|
2008-12-11 |
2015-02-18 |
レスピバート・リミテツド |
ｐ３８ＭＡＰキナーゼ阻害剤
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
EP2686317A4
(en)
*
|
2011-03-17 |
2014-08-20 |
Selexagen Therapeutics Inc |
RAF KINASE INHIBITORS
|
|
AU2012256237B2
(en)
|
2011-05-13 |
2017-01-05 |
Array Biopharma Inc. |
Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as TrkA kinase inhibitors
|
|
BR112014001714A2
(pt)
|
2011-07-26 |
2017-02-14 |
Gruenenthal Gmbh |
derivados de carboxamida e ureia aromáticos bicíclicos substituídos como ligantes de receptor vaniloide
|
|
GB201113538D0
(en)
|
2011-08-04 |
2011-09-21 |
Karobio Ab |
Novel estrogen receptor ligands
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9790210B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
MY178262A
(en)
|
2012-11-13 |
2020-10-07 |
Array Biopharma Inc |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
HRP20161613T1
(hr)
|
2012-11-13 |
2017-01-13 |
Array Biopharma, Inc. |
Tvari bicikličke ureje, tioureje, gvanidina i cijanogvanidina korisne za liječenje boli
|
|
CA2949160C
(en)
|
2014-05-15 |
2023-03-21 |
Array Biopharma Inc. |
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
|
|
GB201721185D0
(en)
|
2017-12-18 |
2018-01-31 |
Nodthera Ltd |
Sulphonyl urea derivatives
|
|
IL276398B2
(en)
|
2018-01-31 |
2026-03-01 |
Deciphera Pharmaceuticals Llc |
Combination therapy for mastocytosis
|
|
KR102708177B1
(ko)
|
2018-01-31 |
2024-09-23 |
데시페라 파마슈티칼스, 엘엘씨. |
위장관 기질 종양의 치료를 위한 병용 요법
|
|
WO2019241311A1
(en)
*
|
2018-06-11 |
2019-12-19 |
Northeastern University |
Selective ligands for modulation of girk channels
|
|
CN109134451A
(zh)
*
|
2018-09-10 |
2019-01-04 |
遵义医学院 |
1,3-二取代脲类与硫脲类衍生物及其应用
|
|
WO2020113094A1
(en)
|
2018-11-30 |
2020-06-04 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
CN109456280B
(zh)
*
|
2018-12-24 |
2020-11-10 |
锦州医科大学 |
含有脲结构的4-苯基噻唑-2-胺类衍生物及其制备方法与应用
|
|
EP3938363A1
(en)
|
2019-03-11 |
2022-01-19 |
Teva Pharmaceuticals International GmbH |
Solid state forms of ripretinib
|
|
PL3983387T3
(pl)
|
2019-06-12 |
2024-08-19 |
NodThera Limited |
Pochodne sulfonylomocznika i ich zastosowania
|
|
KR20220038696A
(ko)
|
2019-07-19 |
2022-03-29 |
아나제네시스 바이오테크놀로지스 에스.에이.에스. |
폴리방향족 우레아 유도체 및 근육 질환 치료에서의 이들의 용도
|
|
LT4013412T
(lt)
|
2019-08-12 |
2026-03-25 |
Deciphera Pharmaceuticals, Llc |
Ripretinibas, skirtas virškinamojo trakto stromos navikų gydymui
|
|
PT4013412T
(pt)
|
2019-08-12 |
2026-03-18 |
Deciphera Pharmaceuticals Llc |
Ripretinib para o tratamento de tumores estromais gastrointestinais
|
|
TWI837402B
(zh)
*
|
2019-12-20 |
2024-04-01 |
大陸商深圳艾欣達偉醫藥科技有限公司 |
含氟化合物、含氟化合物之製備方法及其抗癌醫藥用途
|
|
CN115243681B
(zh)
|
2019-12-30 |
2024-08-16 |
德西费拉制药有限责任公司 |
1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物
|
|
HRP20231699T1
(hr)
|
2019-12-30 |
2024-05-10 |
Deciphera Pharmaceuticals, Llc |
Formulacije inhibitora amorfne kinaze i postupci njihove primjene
|
|
EP4029501A1
(en)
|
2021-01-19 |
2022-07-20 |
Anagenesis Biotechnologies |
Combination of polyaromatic urea derivatives and glucocorticoid or hdac inhibitor for the treatment of diseases or conditions associated with muscle cells and/or satellite cells
|
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|